Pre-transplant microRNA serum profiles and association with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation - Takeaways - MDSpire

Pre-transplant microRNA serum profiles and association with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

  • By

  • Guido Smits

  • Silje Johansen

  • Kristin Paulsen Rye

  • Kimberley Joanne Hatfield

  • Franziska Görtler

  • Guro Kristin Melve

  • Håkon Reikvam

  • May 28, 2026

  • 0 min

Share

  • 1

    Serum microRNA profiles prior to transplantation can predict the risk and severity of acute graft-versus-host disease in allo-HSCT recipients.

  • 2

    In a study of 78 allo-HSCT recipients, 23% developed aGVHD grade II–IV, highlighting the need for early predictive tools.

  • 3

    Eight pretransplant miRNAs were identified as predictive markers for aGVHD, achieving an AUC of 0.855 in ROC analysis.

  • 4

    Hierarchical clustering of miRNA profiles distinguished patients into high and low aGVHD risk groups, with significant differences in incidence.

  • 5

    The findings support integrating pre-transplant miRNA profiling into assessments to guide personalized GVHD prophylaxis and monitoring.

Original Source(s)

Related Content